Arch Therapeutics (ARTH)
(Delayed Data from OTC)
$0.90 USD
+0.13 (17.19%)
Updated Jul 26, 2024 03:46 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Arch Therapeutics, Inc. [ARTH]
Reports for Purchase
Showing records 81 - 100 ( 115 total )
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
What?s Happening with Arch Therapeutics? December Quarter Reported and 510(k) update.
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
To withdraw and resubmit its 510(k) application for AC5.
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
AC5 510(k) Application Withdrawn; Delay Appears Minor; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
We are placing shares of ARTH Under Review, and transferring coverage to ROTH Capital Research due to the departure of the covering analyst.
Provider: Roth Capital Partners, Inc.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Update on FDA Submission - What does FDA posting mean?
Provider: IFS Securities, Inc.
Analyst: BOUCHEY D
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Per Management Meeting, Development of AC5 Is on Track
Provider: Roth Capital Partners, Inc.
Analyst: HIGGINS M
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Favorable Results Reported in Repeat Dose Testing of AC5; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
AC5? Topical Gel 510(k) Filing Submitted on Schedule; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Topical Gel 510(k) Filing Submitted on Schedule; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
510(k) Submitted To FDA For AC5 Topical Gel; Next Up, CE Mark Filing
Provider: Roth Capital Partners, Inc.
Analyst: HIGGINS M
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
Arch Hits Major Milestone - Files for FDA Approval of AC5 Surgical Sealant
Provider: IFS Securities, Inc.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
510(k) Filing Rapidly Approaching; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Arch Therapeutics, Inc.
Industry: Medical - Instruments
510(k) Filing Rapidly Approaching; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.